Summit Therapeutics (SMMT) Other Working Capital Changes (2019 - 2022)

Summit Therapeutics (SMMT) has 9 years of Other Working Capital Changes data on file, last reported at $3000.0 in Q2 2026.

• Quarterly Other Working Capital Changes fell 88.89% year-over-year to $3000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2000.0 (down 100.5% YoY) and the FY2025 annual result came in at $80000.0, down 15.79% from the prior year.
• Other Working Capital Changes grew to $3000.0 in Q2 2026, from -$33000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $12.0 million in Q2 2026 to a low of -$7.0 million in Q4 2023.
• A 5-year average of $1.5 million and a median of $705000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 1669.72% — and 2024, when it jumped 455.17%.
• Tracing SMMT's Other Working Capital Changes over 5 years: stood at $276000.0 in 2022, then sank by 121.01% to -$58000.0 in 2023, then soared by 143.1% to $25000.0 in 2024, then tumbled by 108.0% to -$2000.0 in 2025, then jumped by 250.0% to $3000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $3000.0 (Q2 2026), -$33000.0 (Q1 2026), and -$2000.0 (Q4 2025), per Business Quant data.